The role played by exacerbations in the natural history of chronic obstructive pulmonary disease;El papel de las exacerbaciones en la historia natural de la EPOC

Archivos de Bronconeumologia

Volumn 43, Issue 2, 2007, Pages 55-58

  Soler Cataluña, Juan José ^a  

^a HOSPITAL GENERAL DE REQUENA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE;

BRONCHUS MUCOSA; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; EDITORIAL; FORCED EXPIRATORY VOLUME; HUMAN; MORBIDITY; MORTALITY;

EID: 33847726326     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-2896(07)71028-1     Document Type: Editorial

References (41)

1. Fletcher CM. Chronic bronchitis, its prevalence, nature and pathogenesis. Am Rev Respir Dis. 1959;80:483-94.
2. Fletcher CM, Peto R, Tinker C, Speizer FE. The natural history of chronic bronchitis and emphysema. New York, Toronto: Oxford University Press; 1976.
3. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLB/WHO Global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
4. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-46.
5. Soler JJ, Sánchez L, Martínez MA, Román P, Salcedo E, Navarro M. Mid-arm muscle area is a better predictor of mortality than body mass index in COPD. Chest. 2005;128:2108-15.
6. Schols AMWJ, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr. 2005;82:53-9.
7. Willemse BWM, Ten Hacken NHT, Rutgers B, Lesman-Leegte IGAT, Postma DS, Timens W. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J. 2005;26:835-45.
8. Hogg JC, Chu F, Utokaparch S, Woods R, Elliot WM, Buzatu L, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:2645-53.
9. Sin DD, Man SF. Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link? Thorax. 2006;61:1-3.
10. Donaldson GC, Seemungal TAR, Patel IS, Bhowmik A, Wilkinson TMA, Hurst JR, et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest. 2005;128:1995-2004.
11. Balbi B, Bason C, Balleari E, Fiasella F, Pesci A, Ghio R, et al. Increased bronchoalveolar granulocytes and granulocyte/macrophage colony stimulating factor during exacerbations of chronic bronchitis. Eur Respir J. 1997;10:846-50.
12. Tsoumakidou M, Tzanakis N, Chrysofakis G, Kyriakou D, Siafakas NM. Changes in sputum T-lymphocytes subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary disease. Respir Med. 2005;99:572-9.
13. Bhowmik A, Seemungal TAR, Sapsford RJ. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD. Thorax. 2000;55:114-20.
14. Roland M, Bhowmik A, Sapsford RJ, Seemungal TA, Jeffries DJ, Warner TD, et al. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax. 2001;56:30-5.
15. Gompertz S, O'Brien C, Bayley DL, Hill SL, Stockley RA. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J. 2001;17:1112-9.
16. Patel IS, Seemungal TAR, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax. 2002;57:759-64.
17. Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847-52.
18. 1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167:1090-5.
19. 1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173:871-6.
20. Vestbo J, Lange P. Can GOLD stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med. 2002;166:329-32.
21. 1 decline and COPD morbidity. Am J Respir Crit Care Med. 1996;153:1530-5.
22. Noguera A, Malo O, Sauleda J, Busquets X, Miralles C, Agustí AGN. Inflamación sistémica durante las agudizaciones de la enfermedad pulmonar obstructiva crónica. Arch Bronconeumol. 2002;38:172-6.
23. Hurst JR, Perera W, Wilkinson TM, Donaldson GC, Wedzicha JA. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173:71-8.
24. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular disease? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107:1514-9.
25. Man SFP, Connet JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax. 2006;61:849-53.
26. Connors AF, Dawson NV, Thomas C, Harrell FE, Desbiens N, Fulkerson WJ, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med. 1996;154:959-67.
27. Almagro P, Calbo E, Ochoa de Echagüen A, Barreiro B, Quintana S, Heredia JL, et al. Mortality after hospitalization for COPD. Chest. 2002;121:1441-8.
28. Groenewegen KH, Schols AMWJ, Wouters E. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124:459-67.
29. Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:925-31.
30. Lightowler JV, Wedzicha JA, Elliot MW, Ram FS. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ. 2003;326:185-9.
31. Plant PK, Owen JL, Elliot MW. Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome. Thorax. 2001;56:708-12.
32. Alsaedi A, Sin DD, McAlister FA. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomised placebo-controlled trials. Am J Med. 2002;113:59-65.
33. Sin DD, Wu L, Anderson JA, Anthonisen NR, Buist AS, Burge PS, et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax. 2005;60:992-7.
34. Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsuik A, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2003;361:449-56.
35. Szafransky W, Cukier A, Ramírez A, Menga G, Sansores R, Nahabedian S, et al. Efficacy and safety of budesonide/formoterol and formoterol in chronic obstructive pulmonary diseases. Eur Respir J. 2003;22:912-8.
36. Ferguson T, Calverley PMA, Anderson JA, Celli B, Jenkins C, Jones PW, et al. The TORCH (TOwards a Revolution in COPD Health) study: salmeterol/ fluticasone propionate (SFC) improves survival in COPD over three years. Eur Respir J 2006; 28: Suppl. 50, 34s
37. Niewoehner DE, Rice K, Cote C, et al. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial. Ann Intern Med. 2005;143:317-26.
38. García-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population-based cohort study. Thorax. 2006;61:772-8.
39. White AJ, Gompertz S, Bayley DL, Hill SL, O'Brien C, Unsal I, et al. Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax. 2003;58:680-5.
40. Soler JJ, Martínez-García MA, Román P, Orero R, Terrazas S, Martínez-Pechuan A. Eficacia de un programa específico para pacientes con EPOC que presentan frecuentes agudizaciones. Arch Bronconeumol. 2006;42:501-8.
41. Domingo C, Sans-Torres J, Solà J, Espuelas H, Marín A. Efectividad y eficiencia de una consulta monográfica hospitalaria para patientes con EPOC e insuficiencia respiratoria. Arch Bronconeumol. 2006;42:104-12.